Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 4/2022

Content (14 Articles)

Breast Cancer editorial

ASCO update—best of the best

Andreas Petzer

Neuroendocrine Tumor editorial

Neuroendocrine neoplasms revisited—the challenges of reclassifying tumor

Barbara Kiesewetter

Open Access Cholangiocarcinoma short review

ASCO update: hepatocellular and cholangiocellular carcinoma

Angela Djanani

Rectal Cancer short review

ASCO 2022 update: (neo-)adjuvant treatment of colorectal cancer

Gudrun Piringer

Open Access Glioblastoma short review

Best of ASCO 2022—central nervous system tumors

Annette Leibetseder, Anna S. Berghoff

Open Access short review

Best of ASCO 2022—bladder cancer

Martin Pichler

Open Access Lenvatinib short review

Endometrial cancer: news from ASCO

Edgar Petru

Open Access Radiotherapy short review

Essential news of current guidelines: head and neck squamous cell carcinoma

Thorsten Fuereder

Pancreatic Surgery short review

Current standards in the surgical treatment of pancreatic and small intestinal neuroendocrine tumors

Ulla Klaiber, Stefan Stättner

Open Access Neuroendocrine Tumor short review

From morphology to molecular targets—the pathologist’s view in diagnosing gastroenteropancreatic neuroendocrine neoplasms

Hanna Henzinger, Iva Brcic

Open Access Radiotherapy short review

The NET G3 enigma: dealing with a “new” entity

Markus Raderer, Barbara Kiesewetter

Proton Pump Inhibitors short review

Pharmacokinetic drug interactions of oral anticancer drugs

Julia Gampenrieder Satory

Open Access short review

Challenges in integrating molecular profiles into clinical cancer care

Stephan W. Jahn, Philipp J. Jost

Lymphoma case report

Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review

Hasan Cagri Yildirim, Arif Akyildiz, Rashad Ismayilov, Nartan Demirok, Burhan Sami Benli, Deniz Can Guven, Serkan Akin, Suayib Yalcin, Ibrahim Barista

Nov 22
Issue: Special Issue 8/2022
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer (WCLC), August 6th–9th, 2022
Dec 22
Issue: Special Issue 9/2022
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 9th – 13th September 2022

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits